{"id":"W4232907328","doi":"10.1056/nejmoa066403","title":"Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis C virus research","field":"Medicine","cited_by":490,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Valeant Pharmaceuticals International; Gilead Sciences; Vertex Pharmaceuticals; GlaxoSmithKline","keywords":"Medicine; Ribavirin; Regimen; Internal medicine; Gastroenterology; Peginterferon alfa-2a; Hepatitis C virus; Liter; Odds ratio; Hepatitis C; Randomized controlled trial; Confidence interval; Surgery; Immunology; Virus","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002985018,0.0001703099,0.0006528,0.000536535,0.00003820314,0.00001094404,0.0001337966,0.0001164441,0.0008543749],"category_scores_gemma":[0.00259274,0.00009290002,0.00005077248,0.0002618381,0.0001287427,0.00009721422,0.00003279367,0.0006073804,0.000006513164],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000189738,"about_ca_system_score_gemma":0.0004228244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003784693,"about_ca_topic_score_gemma":0.003764057,"domain_scores_codex":[0.9979895,0.00007055699,0.0007593502,0.0001744138,0.0005842682,0.0004218866],"domain_scores_gemma":[0.9979603,0.0008353745,0.0001840157,0.0001681374,0.000253546,0.0005986717],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02823876,0.0001217264,0.03005349,0.000216079,0.0001073908,0.002261875,0.001547584,0.00000160733,0.004720869,0.00005658851,0.03650124,0.8961728],"study_design_scores_gemma":[0.1224522,0.01729196,0.02896779,0.001791451,0.0001770116,0.002716226,0.0006138431,0.0001343181,0.00154655,0.0003841481,0.8237312,0.0001932407],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9566853,0.003545029,0.007496555,0.02487407,0.001054083,0.0007673825,0.000006671975,0.00001814062,0.005552762],"genre_scores_gemma":[0.9828215,0.001945091,0.001934638,0.001005087,0.00484123,0.000002551279,0.000006560642,0.00003707688,0.00740632],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8959795,"threshold_uncertainty_score":0.9354806,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07762475862658684,"score_gpt":0.3874304482813447,"score_spread":0.3098056896547579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}